Search - tctmd.com

Displaying 1 - 5 of 5

Sort: Relevancy | Date

TCT 705: Comparative Outcomes of Endovascular Intervention Versus Bypass Surgery for Peripheral Artery Disease in Patients With Atrial Fibrillation: A Retrospective Analysis of the National Inpatient Sample

Presentation TCT 2024

TCT 705: Comparative Outcomes of Endovascular Intervention Versus Bypass Surgery for Peripheral Artery Disease in Patients With Atrial Fibrillation: A Retrospective Analysis of the National Inpatient Sample

Presenter: Olayiwola Bolaji

October 30, 2024

TCT 995: Comparison of Left Radial Versus Femoral Artery Access for Coronary Angiography and Percutaneous Coronary Intervention After Coronary Artery Bypass Graft Surgery

Presentation TCT 2024

TCT 995: Comparison of Left Radial Versus Femoral Artery Access for Coronary Angiography and Percutaneous Coronary Intervention After Coronary Artery Bypass Graft Surgery

Presenter: Mikael Zhou

October 29, 2024

TCT 25: Endovascular Intervention Versus Bypass Surgery in the Treatment of Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Control Trials

Presentation TCT 2024

TCT 25: Endovascular Intervention Versus Bypass Surgery in the Treatment of Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Control Trials

Presenter: Shadi Halabi

October 27, 2024

Bypass Surgery for the Patient with Critical Limb Ischemia:Where are we in 2016?

Presentation CCVVC 2016

Bypass Surgery for the Patient with Critical Limb Ischemia:Where are we in 2016?

Presenter: Danielle R Bajakian

June 15, 2016

Subintimal Angioplasty (SIA)or Bypass Surgery(BG) in CLI Patients With TASC II Type C/D Lesions. Mid to long term Clinical outcome.

Presentation TCT 2013

Subintimal Angioplasty (SIA)or Bypass Surgery(BG) in CLI Patients With TASC II Type C/D Lesions. Mid to long term Clinical outcome.

Presenter: Sherif Sultan, Niamh Hynes

January 31, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.